Inditalia Refcon Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Dec 2018

Auditor and Management Disclosures and Notes for the quarterly results dated 31 Dec 2018

1. The above results have been reviewed and recommended by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on 28 January 2019.

2. This statement has been prepared in accordance with the Companies {Indian Accounting Standards) Rules, 2015 (Indian AS, notified under Section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable. The Company has adopted Ind-AS with a transaction date of 1st April 2017.

3. The format for unaudited quarterly results as prescribed in SEBI's Circular CIR/CFD/CMD/15/2015 dated 30th November 2015 has been modified to comply with the requirements of SEBIs circular dated 5th July 2016, Ind AS and schedule III (Division II) to the Companies Act, 2013, which are applicable to companies that are required to comply with Ind AS.

4. The Statutory Auditors have carried out a "Limited Review" of the financial results.

5. The Company is engaged in trading of "Biotechnology Research Products" and therefore has only one reportable segment for the purpose of Indian Accounting Standard (Ind-AS) 108 on "Segment Reporting".

6. The figures of previous financial year have been regrouped, wherever necessary.

Sujata Mital
Managing Director